Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > impariment .. and Re Impariment ...
View:
Post by Imedb36 on Mar 17, 2017 9:59am

impariment .. and Re Impariment ...

realy .... when the compagny need to post lost ... just one post impariment ...

this a big problem of all compgany and in all sector ...

with this financial statement you have a negative book value .... you need to analyse revenue ... mmmm
Comment by RodneyCameron on Mar 17, 2017 10:21am
A requirement to post about impairments is that you must know how to spell the word. Revenues were down 8.1% Net Loss was $663.8M GAPP Loss per share is over $25.00   It is abysmal, and not extending the lease on the company jet is not going to turn the company around.  This company is going down the drain.  Restructuring will help the bondholders but the shareholders are cooked ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities